This announcement is a separate document:
共同药业：北京中伦（武汉）律师事务所关于湖北共同药业股份有限公司2023年限制性股票激励计划首次授予事项的法律意见书
Mutual Pharmaceutical: Legal opinion from Beijing Zhonglun (Wuhan) Law Firm on the first award of Hubei Gongyang Pharmaceutical Co., Ltd.'s 2023 restricted stock incentive plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.